Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mei Pan

Showing results (281-290 of 291) with videos related to

Pageof 30
Sort By:
Journal of Clinical Pharmacology|April 25, 2024
Effect of Histamine H2 Receptor Antagonists on All-Cause Mortality in Critically Ill Patients With Essential Hypertension: A Retrospective Cohort StudyJian-Mei Pan, Yu Guo, Fang-Fang Jiang, et al.
Obesity Research & Clinical Practice|January 9, 2023
Bariatric surgery trends and progress in Taiwan: 2010-2021Kuo-Feng Hsu, Hsin-Mei Pan, Po-Chih Chang, et al.
Small Science|April 11, 2025
A Highly Charged Positive Cage Causes Simultaneous Enhancement of Type-II and O<sub>2</sub>-Independent-Type-I Photodynamic Therapy via One-/Two-Photon Stimulation and Tumor Immunotherapy via PANoptosis and FerroptosisXiao-Dong Zhang, Hui-Juan Yu, Shao-Qi Guan, et al.
Oncotarget|September 30, 2015
Hydrogen peroxide inducible clone-5 mediates reactive oxygen species signaling for hepatocellular carcinoma progressionJia-Ru Wu, Chi-Tan Hu, Ren-In You, et al.
Journal of Gynecologic Oncology|April 12, 2024
QL1604 plus paclitaxel-cisplatin/carboplatin in patients with recurrent or metastatic cervical cancer: an open-label, single-arm, phase II trialCheng Fang, Yun Zhou, Yanling Feng, et al.
Therapeutic Advances in Medical Oncology|February 19, 2026
Pegylated liposomal doxorubicin plus carboplatin versus paclitaxel plus carboplatin as first-line therapy for epithelial ovarian cancer (CGCS-04): a multicenter, randomized clinical trialYuanming Shen, Nalan Tu, Beihua Kong, et al.
Chinese Medical Journal|August 29, 2013
Evaluation on the efficacy and safety of domestic bivalirudin during percutaneous coronary interventionDing-cheng Xiang, Xiao-long Gu, Yao-ming Song, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 30, 2021
Pamiparib Monotherapy for Patients with Germline BRCA1/2-Mutated Ovarian Cancer Previously Treated with at Least Two Lines of Chemotherapy: A Multicenter, Open-Label, Phase II StudyXiaohua Wu, Jianqing Zhu, Jing Wang, et al.
The Journal of Pathology|February 27, 2024
KAT8/SIRT7-mediated Fascin-K41 acetylation/deacetylation regulates tumor metastasis in esophageal squamous cell carcinomaDa-Jia Li, Yin-Wei Cheng, Jin-Mei Pan, et al.
Lancet (London, England)|October 19, 2024
Cadonilimab plus platinum-based chemotherapy with or without bevacizumab as first-line treatment for persistent, recurrent, or metastatic cervical cancer (COMPASSION-16): a randomised, double-blind, placebo-controlled phase 3 trial in ChinaXiaohua Wu, Yang Sun, Hongying Yang, et al.
Pageof 30

Showing results (281-290 of 291) with videos related to

Sort By:
Pageof 30
Journal of Clinical Pharmacology|April 25, 2024
Effect of Histamine H2 Receptor Antagonists on All-Cause Mortality in Critically Ill Patients With Essential Hypertension: A Retrospective Cohort StudyJian-Mei Pan, Yu Guo, Fang-Fang Jiang, et al.
Obesity Research & Clinical Practice|January 9, 2023
Bariatric surgery trends and progress in Taiwan: 2010-2021Kuo-Feng Hsu, Hsin-Mei Pan, Po-Chih Chang, et al.
Small Science|April 11, 2025
A Highly Charged Positive Cage Causes Simultaneous Enhancement of Type-II and O<sub>2</sub>-Independent-Type-I Photodynamic Therapy via One-/Two-Photon Stimulation and Tumor Immunotherapy via PANoptosis and FerroptosisXiao-Dong Zhang, Hui-Juan Yu, Shao-Qi Guan, et al.
Oncotarget|September 30, 2015
Hydrogen peroxide inducible clone-5 mediates reactive oxygen species signaling for hepatocellular carcinoma progressionJia-Ru Wu, Chi-Tan Hu, Ren-In You, et al.
Journal of Gynecologic Oncology|April 12, 2024
QL1604 plus paclitaxel-cisplatin/carboplatin in patients with recurrent or metastatic cervical cancer: an open-label, single-arm, phase II trialCheng Fang, Yun Zhou, Yanling Feng, et al.
Therapeutic Advances in Medical Oncology|February 19, 2026
Pegylated liposomal doxorubicin plus carboplatin versus paclitaxel plus carboplatin as first-line therapy for epithelial ovarian cancer (CGCS-04): a multicenter, randomized clinical trialYuanming Shen, Nalan Tu, Beihua Kong, et al.
Chinese Medical Journal|August 29, 2013
Evaluation on the efficacy and safety of domestic bivalirudin during percutaneous coronary interventionDing-cheng Xiang, Xiao-long Gu, Yao-ming Song, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 30, 2021
Pamiparib Monotherapy for Patients with Germline BRCA1/2-Mutated Ovarian Cancer Previously Treated with at Least Two Lines of Chemotherapy: A Multicenter, Open-Label, Phase II StudyXiaohua Wu, Jianqing Zhu, Jing Wang, et al.
The Journal of Pathology|February 27, 2024
KAT8/SIRT7-mediated Fascin-K41 acetylation/deacetylation regulates tumor metastasis in esophageal squamous cell carcinomaDa-Jia Li, Yin-Wei Cheng, Jin-Mei Pan, et al.
Lancet (London, England)|October 19, 2024
Cadonilimab plus platinum-based chemotherapy with or without bevacizumab as first-line treatment for persistent, recurrent, or metastatic cervical cancer (COMPASSION-16): a randomised, double-blind, placebo-controlled phase 3 trial in ChinaXiaohua Wu, Yang Sun, Hongying Yang, et al.
Pageof 30